참고문헌
- Akiyama, T., Bouillet, P., Miyazaki, T., Kadono, Y., Chikuda, H., Chung, U.I., Fukuda, A., Hikita, A., Seto, H., Okada, T., et al. (2003). Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22, 6653-6664. https://doi.org/10.1093/emboj/cdg635
- Boyle, W.J., Simonet, W.S., and Lacey, D.L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342. https://doi.org/10.1038/nature01658
- Chellaiah, M.A., Soga, N., Swanson, S., McAllister, S., Alvarez, U., Wang, D., Dowdy, S.F., and Hruska, K.A. (2000). Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275, 11993-12002. https://doi.org/10.1074/jbc.275.16.11993
- Croke, M., Ross, F.P., Korhonen, M., Williams, D.A., Zou, W., and Teitelbaum, S.L. (2011). Rac deletion in osteoclasts causes severe osteopetrosis. J. Cell Sci. 124, 3811-3821. https://doi.org/10.1242/jcs.086280
- Di Paola, M., Bonechi, E., Provensi, G., Costa, A., Clarke, G., Ballerini, C., De Filippo, C., and Passani, M.B. (2018). Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer's patches of mice. Sci. Rep. 8, 14881. https://doi.org/10.1038/s41598-018-32925-x
- Faccio, R., Teitelbaum, S.L., Fujikawa, K., Chappel, J., Zallone, A., Tybulewicz, V.L., Ross, F.P., and Swat, W. (2005). Vav3 regulates osteoclast function and bone mass. Nat. Med. 11, 284-290. https://doi.org/10.1038/nm1194
- Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodriguez De Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003). Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90-93. https://doi.org/10.1038/nature01921
- Hong, J.M., Teitelbaum, S.L., Kim, T.H., Ross, F.P., Kim, S.Y., and Kim, H.J. (2011). Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation. J. Bone Miner. Res. 26, 657-665. https://doi.org/10.1002/jbmr.241
- Idris, A.I., Sophocleous, A., Landao-Bassonga, E., Canals, M., Milligan, G., Baker, D., van’t Hof, R.J., and Ralston, S.H. (2009). Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab. 10, 139-147. https://doi.org/10.1016/j.cmet.2009.07.006
- Idris, A.I., van't Hof, R.J., Greig, I.R., Ridge, S.A., Baker, D., Ross, R.A., and Ralston, S.H. (2005). Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. 11, 774-779. https://doi.org/10.1038/nm1255
- Ito, Y., Teitelbaum, S.L., Zou, W., Zheng, Y., Johnson, J.F., Chappel, J., Ross, F.P., and Zhao, H. (2010). Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J. Clin. Invest. 120, 1981-1993. https://doi.org/10.1172/JCI39650
- Itokowa, T., Zhu, M.L., Troiano, N., Bian, J., Kawano, T., and Insogna, K. (2011). Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity. Calcif. Tissue Int. 88, 75-86. https://doi.org/10.1007/s00223-010-9435-3
- Itzstein, C., Coxon, F.P., and Rogers, M.J. (2011). The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases 2, 117-130. https://doi.org/10.4161/sgtp.2.3.16453
- Karwad, M.A., Macpherson, T., Wang, B., Theophilidou, E., Sarmad, S., Barrett, D.A., Larvin, M., Wright, K.L., Lund, J.N., and O’Sullivan, S.E. (2017). Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARalpha. FASEB J. 31, 469-481. https://doi.org/10.1096/fj.201500132
- Kim, H.J., Kim, B.K., Ohk, B., Yoon, H.J., Kang, W.Y., Cho, S., Seong, S.J., Lee, H.W., and Yoon, Y.R. (2019a). Estrogen-related receptor gamma negatively regulates osteoclastogenesis and protects against inflammatory bone loss. J. Cell. Physiol. 234, 1659-1670. https://doi.org/10.1002/jcp.27035
- Kim, H.J., Yoon, H.J., Choi, J.Y., Lee, I.K., and Kim, S.Y. (2014). The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity. J. Leukoc. Biol. 95, 337-345. https://doi.org/10.1189/jlb.0713356
- Kim, H.J., Yoon, H.J., Kim, B.K., Kang, W.Y., Seong, S.J., Lim, M.S., Kim, S.Y., and Yoon, Y.R. (2016). G protein-coupled receptor 120 signaling negatively regulates osteoclast differentiation, survival, and function. J. Cell. Physiol. 231, 844-851. https://doi.org/10.1002/jcp.25133
- Kim, H.J., Yoon, H.J., Park, J.W., Che, X., Jin, X., and Choi, J.Y. (2019b). G protein-coupled receptor 119 is involved in RANKL-induced osteoclast differentiation and fusion. J. Cell. Physiol. 234, 11490-11499. https://doi.org/10.1002/jcp.27805
- Kim, H.J., Zhao, H., Kitaura, H., Bhattacharyya, S., Brewer, J.A., Muglia, L.J., Ross, F.P., and Teitelbaum, S.L. (2006). Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116, 2152-2160. https://doi.org/10.1172/JCI28084
- Kim, M.K., Kim, B., Kwon, J.O., Song, M.K., Jung, S., Lee, Z.H., and Kim, H.H. (2019c). ST5 positively regulates osteoclastogenesis via Src/Syk/calcium signaling pathways. Mol. Cells 42, 810-819. https://doi.org/10.14348/molcells.2019.0189
- Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 397, 315-323. https://doi.org/10.1038/16852
- Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176. https://doi.org/10.1016/S0092-8674(00)81569-X
- Lauffer, L.M., Iakoubov, R., and Brubaker, P.L. (2009). GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58, 1058-1066. https://doi.org/10.2337/db08-1237
- McHugh, K.P., Hodivala-Dilke, K., Zheng, M.H., Namba, N., Lam, J., Novack, D., Feng, X., Ross, F.P., Hynes, R.O., and Teitelbaum, S.L. (2000). Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105, 433-440. https://doi.org/10.1172/JCI8905
- McKillop, A.M., Moran, B.M., Abdel-Wahab, Y.H., Gormley, N.M., and Flatt, P.R. (2016). Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocininduced diabetic and incretin-receptor-knockout mice. Diabetologia 59, 2674-2685. https://doi.org/10.1007/s00125-016-4108-z
- Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006). Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. U. S. A. 103, 696-701. https://doi.org/10.1073/pnas.0504187103
- Overton, H.A., Babbs, A.J., Doel, S.M., Fyfe, M.C., Gardner, L.S., Griffin, G., Jackson, H.C., Procter, M.J., Rasamison, C.M., Tang-Christensen, M., et al. (2006). Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 3, 167-175. https://doi.org/10.1016/j.cmet.2006.02.004
- Provensi, G., Coccurello, R., Umehara, H., Munari, L., Giacovazzo, G., Galeotti, N., Nosi, D., Gaetani, S., Romano, A., Moles, A., et al. (2014). Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. Proc. Natl. Acad. Sci. U. S. A. 111, 11527-11532. https://doi.org/10.1073/pnas.1322016111
- Reeve, J.L., Zou, W., Liu, Y., Maltzman, J.S., Ross, F.P., and Teitelbaum, S.L. (2009). SLP-76 couples Syk to the osteoclast cytoskeleton. J. Immunol. 183, 1804-1812. https://doi.org/10.4049/jimmunol.0804206
- Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001). An anorexic lipid mediator regulated by feeding. Nature 414, 209-212. https://doi.org/10.1038/35102582
- Rossi, F., Siniscalco, D., Luongo, L., De Petrocellis, L., Bellini, G., Petrosino, S., Torella, M., Santoro, C., Nobili, B., Perrotta, S., et al. (2009). The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 44, 476-484. https://doi.org/10.1016/j.bone.2008.10.056
- Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., Ofek, O., Stuart, J.M., Bajayo, A., Tam, J., Kram, V., et al. (2010). Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc. Natl. Acad. Sci. U. S. A. 107, 17710-17715. https://doi.org/10.1073/pnas.0912479107
- Stock, K., Kumar, J., Synowitz, M., Petrosino, S., Imperatore, R., Smith, E.S., Wend, P., Purfurst, B., Nuber, U.A., Gurok, U., et al. (2012). Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. Nat. Med. 18, 1232-1238. https://doi.org/10.1038/nm.2827
- Takayanagi, H. (2007). Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304. https://doi.org/10.1038/nri2062
- Takeshita, S., Kaji, K., and Kudo, A. (2000). Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477-1488. https://doi.org/10.1359/jbmr.2000.15.8.1477
- Tam, J., Ofek, O., Fride, E., Ledent, C., Gabet, Y., Muller, R., Zimmer, A., Mackie, K., Mechoulam, R., Shohami, E., et al. (2006). Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol. Pharmacol. 70, 786-792. https://doi.org/10.1124/mol.106.026435
- Teitelbaum, S.L. (2000). Bone resorption by osteoclasts. Science 289, 1504-1508. https://doi.org/10.1126/science.289.5484.1504
- Touaitahuata, H., Blangy, A., and Vives, V. (2014). Modulation of osteoclast differentiation and bone resorption by Rho GTPases. Small GTPases 5, e28119. https://doi.org/10.4161/sgtp.28119
- Vives, V., Laurin, M., Cres, G., Larrousse, P., Morichaud, Z., Noel, D., Cote, J.F., and Blangy, A. (2011). The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J. Bone Miner. Res. 26, 1099-1110. https://doi.org/10.1002/jbmr.282
- Whyte, L.S., Ryberg, E., Sims, N.A., Ridge, S.A., Mackie, K., Greasley, P.J., Ross, R.A., and Rogers, M.J. (2009). The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc. Natl. Acad. Sci. U. S. A. 106, 16511-16516. https://doi.org/10.1073/pnas.0902743106
- Wong, B.R., Josien, R., Lee, S.Y., Sauter, B., Li, H.L., Steinman, R.M., and Choi, Y. (1997). TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080. https://doi.org/10.1084/jem.186.12.2075
- Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95, 3597-3602. https://doi.org/10.1073/pnas.95.7.3597
- Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V.L., Shattil, S.J., Ginsberg, M.H., Ross, F.P., and Teitelbaum, S.L. (2007). Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877-888. https://doi.org/10.1083/jcb.200611083
- Zou, W., Zhu, T., Craft, C.S., Broekelmann, T.J., Mecham, R.P., and Teitelbaum, S.L. (2010). Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts. J. Cell Sci. 123, 2955-2963. https://doi.org/10.1242/jcs.069872
피인용 문헌
- GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide vol.22, pp.3, 2020, https://doi.org/10.3390/ijms22031034
- Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time vol.10, pp.5, 2020, https://doi.org/10.3390/cells10051199